Before I start with this post, I just wanted to say thank you for those companies who have already subscribed to Tecnon Orbichem's new Bio-Materials & Intermediates service! We are thrilled to have very many positive response within a short time of introducing the service.
Now onto the blog's interview with BioAmber CEO Jean-Francois Huc yesterday morning when the company rang the opening bell at the New York Stock Exchange (NYSE).
BioAmber recently finished its IPO (initial public offering) and was able to raised $80m in capital. On July 18, BioAmber also closed a $25m three-year term loan with Hercules Capital. The financing and the capital from the IPO will enable BioAmber to proceed with the construction of its 30 ktpy bio-succinic acid facility in Sarnia, Ontario. BioAmber estimated during the IPO proceeding that the cost of the Sarnia facility will be around $125m.
More on this post...